Amphiregulin Promotes Resistance to Gefitinib in NonSmall Cell Lung Cancer Cells by Regulating Ku70 Acetylation

Multiple molecular resistance mechanisms reduce the efficiency of receptor tyrosine kinase inhibitors such as gefitinib in non-small cell lung cancer (NSCLC). We previously demonstrated that amphiregulin (Areg) inhibits gefitinib-induced apoptosis in NSCLC cells by inactivating the proapoptotic prot...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Busser, Benoît, Sancey, Lucie, Josserand, Véronique, Niang, Carole, Khochbin, Saadi, Favrot, Marie C, Coll, Jean-Luc, Hurbin, Amandine
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2009
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839437/
https://ncbi.nlm.nih.gov/pubmed/19826407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.227
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars